Orgenesis director resigns, Itzhak Vider appointed to board and audit committee

Orgenesis Inc.

Curtis Slipman resigned as director effective July 3, 2024, for personal reasons; no disagreement with company.
Dr. Itzhak Vider appointed to board and Audit Committee effective July 8, 2024, filling the vacancy.
Vider granted initial option for 6,250 shares at $0.65 exercise price, vesting over three years.
Vider receives $40,000 annual cash retainer plus annual option for 12,500 shares under director compensation policy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Curtis Slipman

director

Orgenesis Inc.

Effective: 2024-07-03
Successor: Itzhak Vider
Filed: July 9, 2024, 7:59 PM ET

On July 3, 2024, Curtis Slipman notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons.

Appointed

Itzhak Vider

director

Orgenesis Inc.

Effective: 2024-07-08
Filed: July 9, 2024, 7:59 PM ET

On July 8, 2024, the board of directors of the Company (the “Board”), upon the recommendation of the Nominating Committee of the Board, appointed Dr. Itzhak Vider as a director, effective July 8, 2024, to fill the vacancy on the Board created by Mr. Slipman’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Curtis Slipman resigned as director at Orgenesis Inc..

Action: resigned
Role: director

Exact text from the filing

On July 3, 2024, Curtis Slipman notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Itzhak Vider was appointed as director at Orgenesis Inc..

Action: appointed
Role: director

Exact text from the filing

On July 8, 2024, the board of directors of the Company (the “Board”), upon the recommendation of the Nominating Committee of the Board, appointed Dr. Itzhak Vider as a director, effective July 8, 2024, to fill the vacancy on the Board created by Mr. Slipman’s resignation.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-026623

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.